Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A pediatric oncology group study
β Scribed by S. J. Culbert; J. J. Shuster; V. J. Land; M. D. Wharam; P. R. M. Thomas; R. Nitschke; D. Pinkel; T. J. Vietti
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 538 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Five weekly doses of triple intrathecal (IT) chemotherapy (methotrexate, hydrocortisone, cytosine arabinoside) starting on day 1 of treatment were added to systemic induction therapy in a regimen (Arm 3) that was compared to three other regimens (Arms 1, 2, and 4) in which central nervous system (CN
## Abstract Three therapeutic regimens (6βhr intervals for 6 doses daily for 3 days, and a single infusion) utilizing the same total dose of adriamycin for the induction of remission in children with lateβstage acute leukemia were evaluated in 150 patients. Complete remission rates were 15%, 28%, a
## Background: Children with acute lymphoblastic leukemia (all) who experience hematologic recurrence while receiving chemotherapy or within 6 months after its cessation have a low cure rate. in this study (pediatric oncology group protocol 8303) two methods were examined for improving the outcome